Donlon, N.E.; Sheppard, A.; Davern, M.; O’Connell, F.; Phelan, J.J.; Power, R.; Nugent, T.; Dinneen, K.; Aird, J.; Greene, J.;
et al. Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines. Cancers 2020, 12, 3356.
https://doi.org/10.3390/cancers12113356
AMA Style
Donlon NE, Sheppard A, Davern M, O’Connell F, Phelan JJ, Power R, Nugent T, Dinneen K, Aird J, Greene J,
et al. Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines. Cancers. 2020; 12(11):3356.
https://doi.org/10.3390/cancers12113356
Chicago/Turabian Style
Donlon, Noel E., Andrew Sheppard, Maria Davern, Fiona O’Connell, James J. Phelan, Robert Power, Timothy Nugent, Kate Dinneen, John Aird, John Greene,
and et al. 2020. "Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines" Cancers 12, no. 11: 3356.
https://doi.org/10.3390/cancers12113356
APA Style
Donlon, N. E., Sheppard, A., Davern, M., O’Connell, F., Phelan, J. J., Power, R., Nugent, T., Dinneen, K., Aird, J., Greene, J., Nevins Selvadurai, P., Bhardwaj, A., Foley, E. K., Ravi, N., Donohoe, C. L., Reynolds, J. V., Lysaght, J., O’Sullivan, J., & Dunne, M. R.
(2020). Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines. Cancers, 12(11), 3356.
https://doi.org/10.3390/cancers12113356
